NO20022847L - Nye substituerte tricykliske forbindelser - Google Patents

Nye substituerte tricykliske forbindelser Download PDF

Info

Publication number
NO20022847L
NO20022847L NO20022847A NO20022847A NO20022847L NO 20022847 L NO20022847 L NO 20022847L NO 20022847 A NO20022847 A NO 20022847A NO 20022847 A NO20022847 A NO 20022847A NO 20022847 L NO20022847 L NO 20022847L
Authority
NO
Norway
Prior art keywords
group
atom
compound
lower alkyl
general formula
Prior art date
Application number
NO20022847A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022847D0 (no
Inventor
Shiro Miyoshi
Kohei Ogawa
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Publication of NO20022847D0 publication Critical patent/NO20022847D0/no
Publication of NO20022847L publication Critical patent/NO20022847L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76Dibenzothiophenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20022847A 1999-12-16 2002-06-14 Nye substituerte tricykliske forbindelser NO20022847L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35691499 1999-12-16
PCT/JP2000/008816 WO2001044187A1 (fr) 1999-12-16 2000-12-13 Nouveaux composes tricycliques substitues

Publications (2)

Publication Number Publication Date
NO20022847D0 NO20022847D0 (no) 2002-06-14
NO20022847L true NO20022847L (no) 2002-08-14

Family

ID=18451407

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022847A NO20022847L (no) 1999-12-16 2002-06-14 Nye substituerte tricykliske forbindelser

Country Status (8)

Country Link
US (1) US20030040538A1 (fr)
EP (1) EP1238973A4 (fr)
KR (1) KR20020069215A (fr)
CN (1) CN1423637A (fr)
AU (1) AU1888501A (fr)
CA (1) CA2394778A1 (fr)
NO (1) NO20022847L (fr)
WO (1) WO2001044187A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2407538C (fr) 2000-04-28 2007-01-09 Asahi Kasei Kabushiki Kaisha Nouveaux composes bicycliques
JPWO2002074306A1 (ja) * 2001-03-19 2004-07-08 旭化成ファーマ株式会社 脂肪肝治療薬
KR100622461B1 (ko) * 2001-10-25 2006-09-19 아사히 가세이 파마 가부시키가이샤 2환식 화합물
FR2840304B1 (fr) * 2002-05-29 2007-05-18 Sanofi Synthelabo Derives d'oxophenyl-cyclohexyl-propanolamine, leur preparation et leur application en therapeutique
JP2007533753A (ja) * 2004-04-23 2007-11-22 タケダ サン ディエゴ インコーポレイテッド インドール誘導体及びキナーゼ阻害剤としてのその使用
KR20080067346A (ko) 2005-11-15 2008-07-18 신젠타 파티서페이션즈 아게 비페닐의 제조방법
WO2008051523A2 (fr) * 2006-10-23 2008-05-02 Georgetown University Thérapie anticancéreuse
WO2010019271A1 (fr) 2008-08-15 2010-02-18 Georgetown University Régulateurs fluorescents de l'expression de rassf1a et de la prolifération de cellules cancéreuses humaines
JPWO2010041569A1 (ja) 2008-10-09 2012-03-08 旭化成ファーマ株式会社 インダゾール化合物
CN102171191A (zh) * 2008-10-09 2011-08-31 旭化成制药株式会社 吲唑衍生物
US20100222404A1 (en) * 2008-11-04 2010-09-02 Asahi Kasei Pharma Corporation Indazole derivative dihydrochloride
US20100173829A1 (en) * 2008-11-07 2010-07-08 Aston University Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof
CA2873214C (fr) * 2012-05-11 2021-02-16 Reset Therapeutics, Inc. Sulfonamides contenant du carbazole en tant que modulateurs de cryptochrome
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
WO2017023916A1 (fr) * 2015-08-05 2017-02-09 Georgetown University Petites molécules inhibitrices du récepteur des androgènes et procédés d'utilisation de ces dernières

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816457A (en) * 1980-12-23 1989-03-28 Baldwin John J Aralkylaminoethanol heterocyclic compounds
DE3612831A1 (de) * 1986-04-16 1987-10-22 Basf Ag 1,4-cyclohexandiamine, verfahren zu ihrer herstellung und ihre verwendung als fungizide
GB8926083D0 (en) * 1989-11-17 1990-01-10 Ici Plc Therapeutic agents
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
ATE154935T1 (de) * 1993-06-14 1997-07-15 Pfizer Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
AU715233B2 (en) * 1996-01-10 2000-01-20 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
ES2149742T1 (es) * 1997-07-03 2000-11-16 Asahi Chemical Ind Nuevos compuestos triciclicos que tienen anillos saturados y composiciones medicinales que contienen los mismos.
KR20010080761A (ko) * 1998-12-15 2001-08-22 야마모토 카즈모토 신규한 복소환 화합물 및 이를 함유하는 의약 조성물

Also Published As

Publication number Publication date
CA2394778A1 (fr) 2002-06-14
US20030040538A1 (en) 2003-02-27
CN1423637A (zh) 2003-06-11
WO2001044187A1 (fr) 2001-06-21
EP1238973A4 (fr) 2003-01-22
NO20022847D0 (no) 2002-06-14
KR20020069215A (ko) 2002-08-29
EP1238973A1 (fr) 2002-09-11
AU1888501A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
US6861444B2 (en) Bicyclic compounds
US6545053B1 (en) Tricyclic compounds and drug compositions containing same
JP2690006B2 (ja) 糖尿病及び肥満の治療のための選択的β3作働薬としての置換フェニルスルホンアミド
NO20022847L (no) Nye substituerte tricykliske forbindelser
NO326106B1 (no) Mustarinagonister, farmasoytiske sammensetninger som inneholder slike, samt anvendelse derav ved behandling av en sykdomstilstand
NO340728B1 (no) Kjemiske forbindelser, fremstilling av disse, farmasøytiske preparater omfattende disse samt slike forbindelser for anvendelse i behandling av sykdommer
CA2341525A1 (fr) Derives d'indoline utilises comme ligands des recepteurs 5-ht2b et/ou 5-ht2c
US6172099B1 (en) Tricyclic compounds having saturated rings and medicinal compositions containing the same
KR20070121028A (ko) 치환된 아미노알킬- 및 아미도알킬-벤조피란 유도체
JP4492848B2 (ja) 2環性化合物
US20050197343A1 (en) Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases
NO176603B (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive 8-substituert-2-aminotetraliner
CN110240559A (zh) 2-(2,2-二芳基乙烯基)环胺衍生物及其制备方法
WO2023246836A1 (fr) Nouveau dérivé de styrène substitué par un hétérocycle à cinq chaînons, son procédé de préparation et son utilisation
EP1142883A1 (fr) Nouveaux composes heterocycliques et compositions de medicaments les renfermant
EP0375560B1 (fr) Aryloxypropanolaminotétralines, un procédé pour leur préparation et composés pharmaceutiques les contenant
KR100595963B1 (ko) 인덴 유도체 및 이의 제조방법
US20220112185A1 (en) Novel phenyl propionic acid derivatives and uses thereof
JPH0347165A (ja) ピロールカルボン酸誘導体
WO2001083453A1 (fr) Nouveaux composes tricycliques substitues
WO1994006785A1 (fr) Nouveau derive d'acide sulfonique et son usage medicinal
WO1998043953A1 (fr) Acides naphtalenesulfoniques ou carboxyliques et leur utilisation en tant qu'agonistes atypiques de beta-adrenorecepteur
NZ753053A (en) Phenyl propionic acid derivatives and uses thereof
CN110981786A (zh) 2-芳乙烯基-环胺衍生物及其制备方法和应用

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application